Neftaly’s Commitment to Controlling Malaria in Pregnancy and Reducing Low Birth Weight

Malaria in pregnancy remains a major public health concern, significantly contributing to adverse outcomes such as low birth weight, maternal anemia, and increased infant mortality. Effective interventions are essential to protect mothers and their babies, especially in high-risk areas.

Neftaly is dedicated to controlling malaria in pregnancy through a comprehensive strategy that includes:

• Case Management: Providing timely diagnosis and effective treatment for pregnant women affected by malaria to prevent complications and improve maternal and fetal health outcomes.
• Distribution and Replacement of Long-Lasting Insecticidal Nets (LLINs): Ensuring all pregnant women in LLIN-targeted areas receive LLINs, with regular replacement campaigns to maintain effective protection against mosquito bites throughout pregnancy.
• Intermittent Preventive Treatment in Pregnancy (IPTp): Delivering IPTp with recommended antimalarial drugs specifically in stratum 5 and 6 regions, where malaria transmission risk is highest, to prevent infection and its associated risks.
• Community Engagement and Education: Raising awareness about the importance of using LLINs and adhering to IPTp schedules to protect both mother and child.
• Strengthening Antenatal Care Services: Collaborating with healthcare providers to integrate malaria prevention and treatment into routine antenatal care, ensuring consistent access to these life-saving interventions.

By focusing on these targeted interventions in high-risk areas, Neftaly aims to reduce the burden of malaria in pregnancy and its detrimental effects on newborn health, including lowering the incidence of low birth weight.